ACCELERATED PHARMA, INC. Series A Preferred Stock Purchase WarrantSeries a Preferred Stock Purchase Warrant • October 11th, 2016 • Accelerated Pharma, Inc. • Pharmaceutical preparations
THIS CERTIFIES THAT, for value received, TALLIKUT PHARMACEUTICALS, INC. (the “Holder”), is entitled to subscribe for and purchase, at the Exercise Price (as defined below), from Accelerated Pharma, Inc., a Delaware corporation (the “Company”), shares of the Company’s Series A Convertible Preferred Stock, par value $0.00001 (the “Preferred Stock”), at any time prior to 5:00 p.m., New York time, on February 19, 2021 (the “Warrant Exercise Term”).
SERIES A PREFERRED STOCK PURCHASE WARRANT ARQULE, INC.Series a Preferred Stock Purchase Warrant • November 8th, 2017 • Arqule Inc • Pharmaceutical preparations
THIS SERIES A PREFERRED STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after November 7, 2017 (the “Initial Exercise Date”) and on or prior to the close of business on the fourth-year anniversary of the date of the Stockholder Filing (as defined in the Purchase Agreement) (such 4th anniversary, the “Termination Date”) but not thereafter, to subscribe for and purchase from ArQule, Inc., a Delaware corporation (the “Company”), (i) prior to the Stockholder Filing, up to ______ shares of Series A Preferred Stock or (ii) after the Stockholder Filing, up to ___ shares of Common Stock (together with the Series A Preferred Stock and as subject to adjustment hereunder, the “Warrant Shares”). The purchase price for each Warrant Share shall be equal to the Exercise Price as defined in Section 2(d)
